No Vaccine in Sight – The New Republic

Read article - Quotes Kendall Hoyt, assistant professor of medicine, in an article about how the COVID-19 pandemic is raising questions about the patent system, pandemic preparedness policy, and the value of a private health sector structurally incapable of prioritizing high-risk, low-probability events. "When researchers have to navigate multiple patents to assemble the knowledge required to develop a vaccine, it slows progress," says Hoyt. "Because upstream discoveries and tools are blocked by a tangle of IP protections, the current system is not well suited to responding to global public health needs."